Clinical Trials Browser

Phase 1 × Adenocarcinoma × relugolix × Clear all

NCT06631521 2026-02-05

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Phase 1 Recruiting

Adenocarcinoma, Prostatic Neoplasms